Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -22.80 -1.7% 1,318.80 1,318.60 1,319.00 1,327.60 1,310.40 1,325.80 1,201,041 09:05:30
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 34,114.0 5,442.0 87.6 15.1 53,640

GSK to Buy Affinivax for Up to $3.3 Billion

31/05/2022 7:43am

Dow Jones News

Historical Stock Chart

From Mar 2022 to Sep 2022

Click Here for more Gsk Charts.

By Kyle Morris


GSK PLC said Tuesday that it has agreed to buy clinical-stage biopharmaceutical company Affinivax, Inc. for up to $3.3 billion.

The healthcare company said that it will pay $2.1 billion upfront and up to $1.2 billion in potential development milestones and that the deal is expected to close in the third quarter.

The transaction will provide access to next-generation pneumococcal vaccine candidates and support the development of its vaccines and specialty medicines, GSK said.


Write to Kyle Morris at


(END) Dow Jones Newswires

May 31, 2022 02:28 ET (06:28 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220929 08:20:31